John J. Albers

Q: What Schools Are Affiliated With John J. Albers

John J. Albers is affiliated with the following schools: Johns Hopkins University, University of Washington, University of Münster

John J. Albers's AcademicInfluence.com Rankings

John J. Albers

Economics

#1896

World Rank

#2175

Historical Rank

economics Degrees

Download Badge

Economics

John J. Albers's Degrees

PhD Economics University of Washington
Masters Business Administration University of Washington

Why Is John J. Albers Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John J. Albers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial (1995) (2244)
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. (1990) (2192)
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. (1982) (2155)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. (2001) (1629)
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. (1978) (1288)
Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease (1993) (863)
Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. (1988) (701)
Eight-Year Weight Losses with an Intensive Lifestyle Intervention: The Look AHEAD Study (2014) (537)
Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. (1984) (453)
Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. (1983) (376)
The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. (1977) (362)
Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. (1976) (337)
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. (1993) (333)
Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). (1995) (318)
Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). (1995) (318)
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. (1983) (317)
Isolation and Characterization of Human Plasma Lipid Transfer Proteins (1984) (295)
Apoproteins B and A-I and coronary artery disease in humans. (1984) (288)
Precipitation methods for quantification of lipoproteins. (1986) (287)
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. (2003) (286)
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). (2000) (282)
Radioimmunoassay of human plasma Lp(a) lipoprotein. (1977) (280)
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (1980) (279)
Comparison of current methods for high-density lipoprotein cholesterol quantitation. (1979) (269)
Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. (1982) (260)
Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. (1979) (260)
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). (2013) (259)
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. (1991) (251)
Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. (1979) (248)
Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. (1985) (238)
Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. (1996) (224)
Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. (1993) (221)
Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. (1991) (213)
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. (1978) (212)
Immunoassay of human plasma apolipoprotein B. (1975) (212)
Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. (1982) (206)
Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. (1989) (206)
Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. (1978) (205)
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol. (1984) (198)
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL (2001) (195)
Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study. (1997) (193)
Prevalence of serum lipid abnormalities in chronic hemodialysis. (1977) (188)
Neutralization and Transfer of Lipopolysaccharide by Phospholipid Transfer Protein (*) (1996) (184)
Lipoprotein (a) measurements for clinical application (2016) (182)
Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. (1994) (181)
Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. (1979) (175)
Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. (1986) (169)
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. (1985) (168)
Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. (1988) (165)
Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein Release Lipopolysaccharides from Gram-Negative Bacterial Membranes (2000) (165)
Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. (2000) (163)
Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B. (1975) (162)
The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. (1981) (160)
Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. (1983) (158)
High-density lipoproteins in myocardial infarction survivors. (1978) (151)
Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. (1985) (149)
Phospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells* (2003) (149)
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. (1980) (146)
Epidemiological Correlates of High Density Lipoprotein Subtractions, Apolipoproteins A‐I, A‐II, and D, and Lecithin Cholesterol Acyltransferase: Effects of Smoking, Alcohol, and Adiposity (1985) (140)
Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice (*) (1995) (139)
Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. (1995) (135)
Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. (1993) (134)
Lipoprotein uptake by cultured human arterial smooth muscle cells. (1975) (131)
The unique lipoprotein(a): properties and immunochemical measurement. (1990) (129)
Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen. (1977) (127)
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). (2004) (124)
Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface* (1999) (124)
Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. (1982) (123)
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. (1991) (122)
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. (1993) (122)
Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. (1996) (121)
Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. (1981) (120)
High Density Lipoprotein Composition in Insulin-dependent Diabetes Mellitus (1981) (118)
Abnormal Composition of High Density Lipoproteins in Non-insulin-dependent Diabetics (1982) (117)
Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. (2012) (115)
The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. (1985) (114)
Molecular and macromolecular specificity of human plasma phospholipid transfer protein. (1997) (114)
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials. (1992) (112)
Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. (1999) (111)
Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios. (1979) (111)
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. (1991) (111)
Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate. (1981) (107)
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. (2006) (107)
Precipitation of 125 I-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins. (1971) (106)
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease. (1997) (105)
Effect of human plasma apolipoproteins on the activity of purified lecithin: cholesterol acyltransferase. (1979) (100)
Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro. (1975) (99)
Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. (1986) (99)
Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. (1981) (99)
National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. (1982) (99)
A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. (1990) (98)
Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. (1989) (98)
HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. (1982) (98)
Quantitation of high density lipoproteins (1978) (97)
Physiologic and Supraphysiologic Increases in Lipoprotein Lipids and Apoproteins in Late Pregnancy and Postpartum: Possible Markers for the Diagnosis of “Prelipemia” (1984) (97)
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts. (1978) (96)
Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. (1994) (93)
Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation. (1976) (90)
The effect of a high cholesterol and saturated fat diet on serum high-density lipoprotein-cholesterol, apoprotein A-I, and apoprotein E levels in normolipidemic humans. (1980) (89)
Uptake of Lp (a) lipoprotein by cultured fibroblasts. (1981) (89)
Familial apolipoprotein A-I and C-III deficiency, variant II. (1985) (89)
Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. (1996) (89)
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. (2008) (88)
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study (2011) (87)
Isolation, characterization, and assay of lecithin-cholesterol acyltransferase. (1986) (87)
Characterization and immunoassay of apolipoprotein D. (1981) (86)
Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. (1981) (86)
Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. (1987) (85)
Isolation, characterization, and assay of plasma lipid transfer proteins. (1986) (82)
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. (1984) (81)
Cell‐Associated and Extracellular Phospholipid Transfer Protein in Human Coronary Atherosclerosis (2003) (80)
Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. (2001) (80)
Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men. (1992) (80)
LDL physical and chemical properties in familial combined hyperlipidemia. (1995) (80)
Coffee intake and elevated cholesterol and apolipoprotein B levels in men. (1985) (80)
Evidence for kinetic heterogeneity among human low density lipoproteins. (1986) (78)
Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts. (1981) (76)
Isoelectric fractionation and characterization of polypeptides from human serum very low density lipoproteins. (1971) (76)
INGESTION OF EGG RAISES PLASMA LOW DENSITY LIPOPROTEINS IN FREE-LIVING SUBJECTS (1984) (75)
Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase. (1980) (75)
Molecular genetics of apolipoproteins and coronary heart disease. (1986) (75)
A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. (1991) (74)
Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data. (1996) (74)
TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE") Insight into the Pathogenetic Mechanism (1977) (74)
Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes. (2008) (73)
Population-based reference values for lecithin-cholesterol acyltransferase (LCAT). (1982) (73)
Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia. (1981) (73)
Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys. (1990) (72)
Types of Change in Coronary Stenosis Severity and Their Relative Importance in Overall Progression and Regression of Coronary Disease (1994) (72)
Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial. (2016) (72)
Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency (1991) (71)
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J). (2000) (70)
Human serum lipoproteins. Evidence for three classes of lipoproteins in S fO-2. (1972) (69)
Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. (1989) (69)
Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. (1979) (68)
Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio (1996) (67)
Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein. (1989) (67)
The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects. (1981) (67)
Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis. (1993) (66)
Immunochemical quantification of human plasma Lp(a) lipoprotein (2006) (66)
Purification and characterization of human plasma lecithin:cholesterol acyltransferase. (1976) (66)
PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. (2000) (65)
Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial. (1991) (65)
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol. (1994) (65)
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia. (1978) (63)
Statins of Different Brain Penetrability Differentially Affect CSF PLTP Activity (2006) (62)
Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. (1985) (61)
The inheritance of high density lipoprotein cholesterol and apolipoproteins A-I and A-II. (1984) (60)
An Amphipathic Helical Region of the N-terminal Barrel of Phospholipid Transfer Protein Is Critical for ABCA1-dependent Cholesterol Efflux* (2008) (59)
Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. (2003) (58)
Effect of postpartum lactation on lipoprotein lipids and apoproteins. (1985) (58)
Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. (2006) (58)
Acute Psychological Stress and Epinephrine Infusion in Normolipidemic and Hyperlipidemic Men: Effects on Plasma Lipid and Apoprotein Concentrations (1995) (57)
Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn). (1993) (57)
Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide. (1980) (57)
Rapid regulation of the activity of the low density lipoprotein receptor of cultured human fibroblasts. (1980) (56)
Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro (2005) (55)
Distribution of lecithin-cholesterol acyltransferase (LCAT) in human plasma lipoprotein fractions. Evidence for the association of active LCAT with low density lipoproteins. (1982) (53)
Regulated vectorial secretion of cholesteryl ester transfer protein (LTP-I) by the CaCo-2 model of human enterocyte epithelium. (1988) (53)
Cholesteryl ester transfer protein in human brain (1992) (52)
Apoprotein synthesis by human duodenojejunal mucosa. (1978) (51)
Secretion of a lipid transfer protein by human monocyte-derived macrophages. (1985) (51)
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed For (2009) (51)
Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey. (1981) (51)
Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation. (2010) (51)
The effect of hypoxia on uptake and degradation of low density lipoproteins by cultured human arterial smooth muscle cells. (1976) (49)
Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism (2004) (49)
Lipoprotein abnormalities in primary biliary cirrhosis (1985) (48)
Lecithin: cholesterol acyltransferase in liver disease. (1987) (46)
Low-density lipoproteins modified by lipid transfer protein have altered biological activity. (1984) (46)
High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs. (1980) (46)
Plasma lipid levels and coronary heart disease in adult relatives of newborns with normal and elevated cord blood lipids. (1974) (46)
Apoprotein measurements and their clinical application. (1989) (45)
Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events. (1993) (45)
Short-term egg yolk feeding in humans. Increase in apolipoprotein B and low density lipoprotein cholesterol. (1979) (45)
DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. (1999) (44)
A partial cDNA clone for human apolipoprotein B. (1985) (44)
Use of niacin, statins, and resins in patients with combined hyperlipidemia. (1998) (44)
Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains. (1999) (43)
Effects of interval and continuous running on HDL-cholesterol, apoproteins A-1 and B, and LCAT. (1985) (43)
Regulation of low density lipoprotein receptor activity by cultured human arterial smooth muscle cells. (1977) (43)
Low Density Lipoprotein Receptor Activity in Fibroblasts Cultured from Diabetic Donors (1979) (42)
Biological and Dietary Correlates of Plasma Lipids and Lipoproteins among Elderly Japanese Men in Hawaii (1986) (42)
Regression of coronary artery disease as a result of intensive lipid-lowering therapy. (1991) (42)
High-density lipoprotein-cholesterol in survivors of myocardial infarction. (1979) (42)
A cysteine-containing truncated apo A-I variant associated with HDL deficiency. (1996) (41)
Standardization of apolipoprotein B and A-I measurements. (1989) (41)
HDL‐3 is a Superior Predictor of Carotid Artery Disease in a Case‐Control Cohort of 1725 Participants (2014) (40)
Associations of diet and alcohol intake with high-density lipoprotein subclasses. (1985) (40)
International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B (1990) (40)
Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. (2002) (40)
Regulation of plasma lipid transfer by the high-density lipoproteins. (1988) (40)
Synthesis and Secretion of Plasma Cholesteryl Ester Transfer Protein by Human Hepatocarcinoma Cell Line, HepG2 (1987) (40)
Electron-beam tomography coronary calcium scores are superior to Framingham risk variables for predicting the measured proximal stenosis burden. (2001) (39)
A novel view of albumin-supported sperm capacitation: role of lipid transfer protein-I. (1993) (39)
Quality Control of Plasma High‐density Lipoprotein Cholesterol Measurement Methods: The Lipid Research Clinics Program Prevalence Study (1980) (39)
Lipid and lipoprotein triglyceride and cholesterol interrelationships: effects of sex, hormone use, and hyperlipidemia. (1984) (39)
Molecular biology of phospholipid transfer protein (1996) (39)
Plasma Lipids and Microangiopathy in Insulin-dependent Diabetes Mellitus (1981) (39)
Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease. (1993) (38)
Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. (1989) (38)
Ultrastructural immunolocalization of apolipoprotein B within human jejunal absorptive cells. (1983) (37)
Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men. (1990) (37)
Estrogen-induced increase in uptake of cholesterol-rich very low density lipoproteins in perfused rabbit liver. (1981) (37)
Effects of Intensive Lipid‐Lowering Therapy on the Coronary Arteries of Asymptomatic Subjects With Elevated Apolipoprotein B (1993) (37)
Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene. (2001) (37)
Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. (1987) (37)
Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men. (1985) (36)
Effects of lyophilization of serum on the measurement of apolipoproteins A-I and B. (1990) (36)
PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity. (2003) (36)
Interspecies activation of lecithin-cholesterol acyltransferase by apolipoprotein A-I isolated from the plasma of humans, horses, sheep, goats and rabbits. (1983) (35)
Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. (2002) (35)
PLTP regulates STAT3 and NFκB in differentiated THP1 cells and human monocyte-derived macrophages. (2011) (35)
Evidence mounts for a role of the kidney in lipoprotein(a) catabolism. (2007) (35)
Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease. (1999) (34)
Lipoprotein Lipase (LPL) is Associated with Neurite Pathology and Its Levels Are Markedly Reduced in the Dentate Gyrus of Alzheimer’s Disease Brains (2013) (34)
Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins Published, JLR Papers in Press, March 6, 2006. (2006) (33)
Comparison of two commercial nephelometric methods for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays. (1989) (33)
Differential effects of simvastatin and pravastatin on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells (2009) (32)
Regulation of LTP-I secretion from human monocyte-derived macrophages by differentiation and cholesterol accumulation in vitro. (1990) (32)
Organization of human phospholipid transfer protein gene. (1995) (31)
Comparison of commercial kits for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays performed at the Northwest Lipid Research Center. (1988) (31)
A rapid large-scale procedure for purification of lecithin-cholesterol acyltransferase from human and animal plasma. (1985) (31)
Genetic and nongenetic sources of variation in phospholipid transfer protein activity[S] (2010) (31)
Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. (1987) (31)
Phospholipid transfer protein reduces phosphorylation of tau in human neuronal cells (2009) (31)
Effect of positively charged sphingomyelin liposomes on cholesterol metabolism of cells in culture. (1983) (30)
Isoelectric heterogeneity of the major polypeptide of human serum high density lipoproteins (1971) (30)
Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution DOI 10.1194/jlr.M100373-JLR200 (2002) (30)
Evaluation of a new homogenous method for detection of small dense LDL cholesterol: comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugation. (2011) (29)
In Vitro Expression of Structural Defects in the Lecithin-Cholesterol Acyltransferase Gene (*) (1995) (29)
Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice. (2002) (29)
Synthesis and secretion of lecithin-cholesterol acyltransferase by the human hepatoma cell line HepG2. (1986) (28)
Effect of storage on the measurement of apolipoproteins A-I and A-II by radial immunodiffusion. (1980) (28)
Plasma lipoprotein metabolism in familial lecithin:cholesterol acyltransferase deficiency. (1974) (28)
Standardization of the Immunochemical Determination of Apolipoproteins A-I and B: A Report on the International Federation of Clinical Chemistry Meeting on Standardization of Apolipoprotein A-I and B Measurements (Basis for Future Consensus), Vienna, Austria, April 18-19, 1989 (1989) (28)
Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency. (1981) (27)
HDL cholesterol: results of interlaboratory proficiency tests. (1980) (27)
Further characterization of purified lecithin: cholesterol acyltransferase from human plasma. (1981) (27)
ASSOCIATION OF ISOAPOLIPOPROTEIN-E3 DEFICIENCY WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA: IMPLICATIONS FOR LIPOPROTEIN PHYSIOLOGY (1981) (27)
Plasma lipoprotein analysis: relative precision of total cholesterol and lipoprotein-cholesterol measurements in 12 lipid-research-clinics laboratories. (1981) (27)
Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: kinetic analysis using an integrated model. (1986) (26)
Interlaboratory proficiency survey of high-density lipoprotein cholesterol measurement. (1983) (26)
Type III hyperlipoproteinemia: a comparative study of current diagnostic techniques. (1977) (26)
Familial high‐density‐lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent (1992) (26)
Purification and molecular cloning of human apolipoprotein F. (1994) (25)
Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men. (1988) (25)
Localization of the human phospholipid transfer protein gene to chromosome 20q12-q13.1. (1995) (25)
Screening for lipoprotein[a] elevations in plasma and assessment of size heterogeneity using gradient gel electrophoresis. (1989) (25)
Effect of donor age on the binding and degradation of low density lipoproteins by cultured human arterial smooth muscle cells. (1979) (25)
Reduction of plasma triglyceride concentration by acute stress in man. (1979) (25)
Apoprotein B in fasting and postprandial human jejunal mucosa. (1976) (25)
Evaluation of quality-control materials for high-density-lipoprotein cholesterol quantitation. (1981) (25)
Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain (1992) (25)
Metabolism of Low Density Lipoprotein by Bovine Endothelial Cells as a Function of Cell Density (1984) (24)
Secondary prevention of heart disease amongst patients with lipid abnormalities: practice and trends in the United States (1997) (24)
Identification and genetic control of two new low-density lipoprotein allotypes: phenogroups at the Lpq locus. (1969) (22)
Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology. (2009) (22)
Plasma Lipids and Lipoproteins in Elderly Japanese‐American Men (1986) (22)
Functional characterization of the promoter region of the human phospholipid transfer protein gene. (1995) (22)
SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction. (2008) (22)
Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele (1990) (21)
Quantitative Trait Locus Mapping of Genes That Regulate Phospholipid Transfer Activity in SM/J and NZB/BlNJ Inbred Mice (2004) (21)
Familial lecithin-cholesterol acyltransferase deficiency in four Norwegian Families. Evidence for low levels of a functionally defective enzyme. (2009) (21)
Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design. (1998) (21)
Molecular basis of fish-eye disease in a patient from Spain. Characterization of a novel mutation in the LCAT gene and lipid analysis of the cornea. (1997) (21)
Lecithin: cholesterol acyltransferase deficiency: identification of two defective alleles in fibroblast cDNA. (1995) (20)
Lipoprotein(a) quantification: comparison of methods and strategies for standardization (1994) (19)
Lipid transfer protein-mediated distribution of HDL-derived cholesteryl esters among plasma apo B-containing lipoprotein subpopulations. (1993) (19)
Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin. (2001) (19)
Studies on the cofactor requirement for the acylation and hydrolysis reactions catalyzed by purified lecithin-cholesterol acyltransferase. Effect of low density lipoproteins and apolipoprotein A-i. (1982) (19)
Measurement of apolipoproteins A-I and B during the National Health and Nutrition Examination Survey (NHANES) III. (1994) (19)
Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration (2017) (19)
Characterization of the mouse gene encoding phospholipid transfer protein. (1997) (19)
Evaluation of the measurement of B protein of plasma low density lipoprotein by radial immunodiffusion. (1985) (19)
Simvastatin plus niacin protect against atherosclerosis progression and clinical events in coronary artery disease patients with metabolic syndrome (2002) (18)
Stimulation of lecithin:cholesterol acyltransferase activity by apolipoprotein A-II in the presence of apolipoprotein A-I. (1986) (18)
Ophthalmic observations in lecithin cholesterol acyltransferase deficiency. (1988) (18)
Lipoprotein quantification: an electrophoretic method compared with the Lipid Research Clinics method. (1982) (18)
Stimulation of human sperm capacitation by purified lipid transfer protein. (1995) (18)
Lecithin-Cholesterol Acyltransferase (1981) (18)
PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity1[S] (2015) (17)
Apolipoprotein assays: standardization and quality control. (1990) (17)
Allelic exclusion and phenogroup expression in individual molecules of rabbit low-density lipoprotein allotypes. (1969) (17)
Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels. (1989) (17)
Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP). (2018) (17)
Plasma lipoproteins. Part A: Preparation, structure, and molecular biology. (1986) (16)
Physiological and analytical variation in cholesterol and triglycerides (1976) (16)
PLTP is present in the nucleus, and its nuclear export is CRM1-dependent. (2009) (15)
Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein. (2011) (15)
Evaluation of commercial heparin preparations for use in the heparin-Mn2+ method for measuring cholesterol in high-sensity lipoprotein. (1979) (15)
Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency. (1997) (15)
Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice (1999) (15)
LIPOPROTEIN UPTAKE AND DEGRADATION BY HUMAN ARTERIAL SMOOTH MUSCLE CELLS IN TISSUE CULTURE * (1976) (15)
Effects of sample aging on total cholesterol values determined by the automated ferric chloride-sulfuric acid and Liebermann-Burchard procedures. (1980) (15)
comparison of Plasma Lipoproteins and Apoproteins in Chinese and American Non-Insulin-Dependent Diabetic Subjects and Controls (1986) (15)
Response of HDL cholesterol, apoprotein A-I, and LCAT to exercise withdrawal. (1985) (15)
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables. (2014) (15)
Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma. (1988) (14)
The effect of hydrocortisone on cholesterol metabolism of cultured human skin fibroblasts. (1981) (14)
Linkage and association of phospholipid transfer protein activity to LASS4[S] (2011) (14)
DNA sequences essential for transcription of human phospholipid transfer protein gene in HepG2 cells. (1997) (14)
Comparison of Methods of Plasma Triglyceride Turnover (1977) (14)
Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband. (1998) (14)
Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. (2008) (14)
Lack of correlation between serum lipoproteins and biliary cholesterol saturation in patients with gallstones (1984) (13)
Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein (1990) (13)
Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries. (1980) (13)
Relationships of gender, sex hormone use, and age with lipoprotein cholesterol/triglyceride ratios in an adult population. The Pacific Northwest Bell Telephone Company health survey. (1981) (13)
International Federation of Clinical Chemistry study on the standardization of apolipoproteins A-I and B (1991) (13)
Secretion of cholesteryl ester transfer protein-lipoprotein complexes by human HepG2 hepatocytes. (1989) (13)
Standardization of Lp(a) measurements. (1994) (13)
Impaired intermediate-density lipoprotein triglyceride hydrolysis in familial lecithin:cholesterol acyltransferase (LCAT) deficiency. (1987) (12)
Regression of atherosclerosis. Does it occur and does it have clinical meaning? (1995) (12)
Effect of human plasma apolipoproteins on the activity of purified lecithin:cholesterol acyltransferase. (1978) (12)
Phospholipid transfer protein maps to distal mouse chromosome 2. (1996) (12)
Workshop on apolipoprotein quantification. (1983) (12)
Quantitative genetic studies of the human plasma Lp(a) lipoprotein (1974) (12)
What benefit can be derived from treating normocholesterolemic patients with coronary artery disease? (1995) (12)
Preparation, structure, and molecular biology (1986) (12)
Lipoprotein uptake and degradation by cultured human arterial smooth muscle cells. (1976) (11)
Defective enzyme causes lecithin-cholesterol acyltransferase deficiency in a Japanese kindred. (1985) (11)
Chapter 10 – The Measurement of Lp(a) and Its Clinical Application (1990) (11)
Identification and genetic control of two rabbit low-density lipoprotein allotypes (1968) (11)
Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey: Part 2. Lipoprotein Lipid Interrelationships (1983) (11)
Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey: Part 1. Lipoprotein Cholesterol and Triglyceride Concentrations (1983) (11)
Effect of total parenteral nutrition with intravenous fat on lipids and high density lipoprotein heterogeneity in neonates. (1989) (11)
Multilaboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates. (1981) (10)
Phospholipid transfer protein interacts with and stabilizes ABCA 1 and enhances cholesterol efflux from cells * (2003) (10)
Abnormal composition of apoproteins C-I, C-II, and C-III in plasma and very-low-density lipoproteins of non-insulin-dependent diabetic Chinese. (1986) (10)
Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity. (2011) (10)
Role of HDL, LCAT, and Lipid Transfer Protein in Lipoprotein Metabolism (1985) (8)
Widespread distribution of PLTP in human CNS Published, JLR Papers in Press, April 1, 2003. DOI 10.1194/jlr.M300046-JLR200 (2003) (8)
Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels (1992) (8)
Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients. (2010) (8)
Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study. (2016) (8)
Role of low density lipoprotein in the activation of plasma lysolecithin acyltransferase activity. Effect of chemical and enzymatic modifications of the lipoprotein on enzyme activity. (1985) (7)
Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia (1987) (7)
Inhibition of thrombin generation in human plasma by phospholipid transfer protein (2015) (7)
Plasma cholesteryl ester and phospholipid transfer proteins and their regulation. (1988) (6)
A novel missense mutation (Asn5→Ile) in lecithin: cholesterol acyltransferase (LCAT) gene in a Japanese patient with LCAT deficiency (1996) (6)
Host and environmental effects on plasma apolipoprotein B (1993) (6)
Methodological Considerations in Apolipoprotein Immunoassay (1980) (6)
International Federationof Clinical Chemistry StandardizationProject for Measurementsof ApolipoproteinsA-I and B. IV. Comparabilityof Apolipoprotein B Values by Use of InternationalReferenceMaterial (1994) (5)
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity). (1987) (5)
Apolipoprotein A-I in liver disease. (1987) (5)
Studies of lipoproteins and fatty acids in maternal and cord blood of two racial groups in Trinidad (1987) (5)
Lipid-lowering therapy prevents instability among mild and moderate atherosclerotic plaques: Observations from fats (1992) (4)
Apolipoprotein B, a hidden risk factor among patients requiring invasive therapy for coronary artery disease (1990) (4)
Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM / J and NZB / B 1 NJ inbred mice (2002) (4)
Plaque regression and clinical events in coronary disease (1992) (4)
Cholesterol Homeostasis of Skin Fibroblasts after Incubation with Postabsorptive and Postprandial Lipoproteins: The Effect of a Fatty Meal (1982) (4)
A-l and Coronary Artery Disease in Humans (2005) (4)
Binding of High Density Lipoproteins to Cultured Human Skin Fibroblasts and Arterial Smooth Muscle Cells (1983) (3)
Familial lecithin-cholesterol acyltransferase: Identification of heterozygotes with half-normal enzyme activity and mass (2004) (3)
Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: Evidence for functionally defective enzyme in homozygotes and obligate heterozygotes (2004) (3)
The Determination of Apoproteins and their Diagnostic Value in Clinical Chemistry (1982) (3)
Atherosclerosis Regression and Plaque Stabilization: A Rationale for Lipid-lowering in Coronary Artery Disease (1995) (3)
Increased potential for regression of post-PTCA restenosis using intensive lipld-altering therapy: Comparison with matched non-PTCA lesions (1991) (3)
Conifer desiccation in the 2021 NW heatwave confirms the role of hydraulic damage. (2022) (3)
Plasma cholesterol, ageing and lecithin:cholesterol acyltransferase. (1988) (3)
International Federation of Clinical Chemistry (IFCC) Scientific Division. Committee on Apolipoproteins, Working Group on Antibody Reagents. Selection and characterization of monoclonal antibodies for measuring plasma levels of apolipoproteins A-I and B. (1990) (3)
Characterization, cell biology, and metabolism (1986) (2)
Steroid contraceptives and human lipoprotein metabolism: effects and mechanisms. (1977) (2)
Lipoprotein Heterogeneity Workshop (2005) (2)
Measurements for Clinical Application (2015) (2)
Cholesterol and triglyceride distributions in an adult employee population: The Pacific Northwest Bell Telephone Company health survey (1980) (2)
Regulation of low density lipoprotein degradation by triiodothyronine (1978) (2)
Plasma and lipoprotein lipid responses to four hypolipid drugs (1984) (2)
Genetic and Phenotypic Heterogeneity in Familial Lecithin : Cholesterol Acyltransferase ( LCAT ) Deficiency (2013) (2)
Effect of moderate alcohol intake on serum apolipoproteins in man. A controlled study (1984) (1)
Plasma lipoproteins. B. Characterization, cell biology, and metabolism. (1986) (1)
The national cooperative gallstone study: Effect of chenodeoxycholic acid on lipoproteins (1981) (1)
Lack of association between plasma lecithin: cholesterol acyltransferase concentration and plasma sex hormone concentrations in men. (1988) (1)
THE NATIONAL COOPERATIVE GALLSTONE STUDY (1981) (1)
DextranSulfate-Mg2 Precipitation Procedure forQuantitation of High- Density-Lipoprotein Cholesterol (1982) (1)
Radioimmunoassay of human plasma Lp(a) I i pop rote in (1977) (1)
of apolipoproteins A-I and A-Il by radial immunodiffusion (1980) (1)
Low-Density Lipoprotein Inhibits Secretion of Phospholipid Transfer Protein in Human Trophoblastic BeWo Cells (2004) (1)
Evaluation of assayed chemistry control pools for measurement of high-density lipoprotein. (1984) (1)
The Complex Genetics of Type III Hyperlipoproteinemia: Influence of Co-inherited Monogenic Hyperlipidemia upon the Phenotypic Expression of Apolipoprotein E3 Deficiency (1980) (1)
Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial (2019) (1)
PLTP activity decreases with weight loss Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300073-JLR200 (2003) (1)
Familial apolipoprotein A-I and CIll deficiency , variant IV (2002) (0)
Lecithin-Cholesterol Acyltransferase and Plasma Lipid Transfer Protein (1987) (0)
Symposium - Is medical treatment of coronary artery disease superior to revasculation procedures?, Vancouver, BC, Canada, 31 May 1997 (1998) (0)
The effect of insulin on the interaction of lipoproteins with cultured cells (1977) (0)
Ethanol impairs low density lipoprotein metabolism by cultured human cells (1978) (0)
P3-035 CSF PLTP-mediated phospholipid transfer activity in Alzheimer's disease (2004) (0)
Coffee Intake and Serum Lipids in Men-Reply (1985) (0)
Apoprotein measurements. (1985) (0)
LDL binding to its cellular receptor (1978) (0)
[Lipoprotein synthesis by the human intestine]. (1978) (0)
Abstract 20534: Effects of Extended Release Niacin on HDL Particles and Other Parameters in an Intervention Trial (2017) (0)
[A comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin dependent diabetes mellitus and controls]. (1986) (0)
Heparin-Mn 2 Quantitationof High-Density-LipoproteinCholesterol : An UltrafiltrationProcedure for Lipemic Samples (2004) (0)
Multi-LaboratoryComparison of Three Heparin-Mn 2 Precipitation Procedures for EstimatingCholesterol in High-DensityLipoprotein (2004) (0)
Acknowledgement to reviewers (2010) (0)
Mo-W2:3 Lipoprotein abnormalities and glucose control in youth with type 1 and type 2 diabetes (2006) (0)
Synthesis and Secretion of Plasma Cholesteryl Ester Transfer Protein by Human Hepatocarcinoma Cell Line , HepG 2 (2005) (0)
Fasting insulin and C-peptide values do not predict coronary disease severity or its progression over 2.5 years in non-diabetic patients with coronary artery disease (1996) (0)
BRITISH ALLERGY SOCIETY (1972) (0)
Angelo Scanu Memorial (2018) (0)
Book Review:High Density Lipoproteins and Atherosclerosis. A. M. Gotto, Jr., N. E. Miller, M. F. Oliver (1979) (0)
[Standardization of the immunochemical detection of apolipoprotein A-I and B]. (1990) (0)
Subject Index Vol. 22, 2006 (2006) (0)
Lipid Accumulation and Plaque Disruption: Processes Triggering Clinical Instability in Coronary Disease (1995) (0)
Estrogen-induced increase in uptake of cholesterol-rich very low density lipoproteins (VLDL) by perfused rabbit liver (1981) (0)
Accelerated vascular disease following renal transplantation. (1977) (0)
Measurementof Apolipoproteins A-I and B Duringthe NationalHealthand Nutrition ExaminationSurvey(NHANES)III (1994) (0)
Meeting Summary Workshop on Apolipoprotein Quantification (2005) (0)
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (1980) (0)
Isoelectric heteogeneity of the major polypeptide of human serum high density lipoproteins. (1971) (0)
2 Role of high density lipoprotein subclasses in reverse cholesterol transport (2012) (0)
Poster abstractIdentification of a novel mutation (Arg99 → Cys) in the LCAT gene causing Fish Eye Disease in a Spanish family (1994) (0)
HDLC as a therapeutic target in coronary disease: current concepts and future directions (1995) (0)
In Memoriam: Angelo Scanu (1924-2018)1 (2018) (0)
Contents Vol. 22, 2006 (2006) (0)
Measurement of ApolipoproteinsA-I and B During the National Health and Nutrition Examination Survey (NHANES) III (2004) (0)
Type III hyperlipidemia (1975) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John J. Albers?

John J. Albers is affiliated with the following schools: